1. Non-ischemic dilated cardiomyopathy and cardiac fibrosis
   Bianca Olivia Cojan-Minzat et al, 2020, Heart Fail Rev CrossRef
2. Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
   Sara Panizo et al, 2021, IJMS CrossRef
3. MicroRNA Profiling of HL-1 Cardiac Cells-Derived Extracellular Vesicles
   Serena Silvestro et al, 2021, Cells CrossRef
4. MicroRNA-30a-5p silencing polarizes macrophages toward M2 phenotype to alleviate cardiac injury following viral myocarditis by targeting SOCS1
   Yan Zhang et al, 2021, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
5. MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling
   Liana Maries et al, 2021, Diagnostics CrossRef
6. Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics
   Jinhong Chen et al, 2021, Front. Genet. CrossRef
7. miR-30a-5p inhibits the proliferation and collagen formation of cardiac fibroblasts in diabetic cardiomyopathy
   Xiao-xu Yang et al, 2022, Can. J. Physiol. Pharmacol. CrossRef
8. α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis
   Yosuke Kanno et al, 2022, Life CrossRef
9. Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis
   Minghui Wang et al, 2024, Front. Pharmacol. CrossRef